Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA.

Wataganara T, Metzenbauer M, Peter I, Johnson KL, Bianchi DW.

Am J Obstet Gynecol. 2005 Aug;193(2):496-500.

PMID:
16098876
2.

High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery.

Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, Bianchi DW.

Am J Obstet Gynecol. 2005 Aug;193(2):421-5.

PMID:
16098864
3.

[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].

Hou QF, Wu D, Chu Y, Kang B, Liao SX, Yang YL, Zhang CY, Zhang JX, Wu G.

Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7. Chinese.

PMID:
23302120
4.

A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.

Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B.

Prenat Diagn. 2006 Sep;26(9):831-6.

PMID:
16832830
5.

Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester.

Majer S, Bauer M, Magnet E, Strele A, Giegerl E, Eder M, Lang U, Pertl B.

Prenat Diagn. 2007 Dec;27(13):1219-23.

PMID:
17968856
6.

Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.

AbdelHalim RM, Ramadan DI, Zeyada R, Nasr AS, Mandour IA.

Mol Diagn Ther. 2016 Apr;20(2):135-49. doi: 10.1007/s40291-015-0184-x.

PMID:
26790664
7.

Three-dimensional sonographic volumetry of the placenta and the fetus between weeks 15 and 17 of gestation.

Hafner E, Schuchter K, van Leeuwen M, Metzenbauer M, Dillinger-Paller B, Philipp K.

Ultrasound Obstet Gynecol. 2001 Aug;18(2):116-20.

8.

The influence of leptin on placental and fetal volume measured by three-dimensional ultrasound in the second trimester.

Woelfer B, Hafner E, Metzenbauer M, Schuchter K, Philipp K.

Placenta. 2005 Feb-Mar;26(2-3):124-8.

PMID:
15708113
9.

Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters.

Metzenbauer M, Hafner E, Hoefinger D, Schuchter K, Stangl G, Ogris E, Philipp K.

Placenta. 2001 Jul;22(6):602-5.

PMID:
11440550
10.

Fetal nucleic acids in maternal body fluids: an update.

Bianchi DW, Wataganara T, Lapaire O, Tjoa ML, Maron JL, Larrabee PB, Johnson KL.

Ann N Y Acad Sci. 2006 Sep;1075:63-73.

PMID:
17108193
11.
12.

Unexplained fetal death: another anti-angiogenic state.

Espinoza J, Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Nien JK, Kusanovic JP, Erez O, Bujold E, Gonçalves LF, Gomez R, Edwin S.

J Matern Fetal Neonatal Med. 2007 Jul;20(7):495-507.

PMID:
17674262
13.

Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy.

Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW, Johnson KL.

Fertil Steril. 2004 Mar;81(3):638-44.

PMID:
15037414
14.

Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels.

Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW.

Obstet Gynecol. 2004 Sep;104(3):545-50.

PMID:
15339767
15.

Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation.

Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Mazaki-Tovi S, Dong Z, Kim SK, Ogge G, Yeo L, Mittal P, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Oct;23(10):1097-105. doi: 10.3109/14767050903551509.

16.

A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection.

Xu XP, Gan HY, Li FX, Tian Q, Zhang J, Liang RL, Li M, Yang XX, Wu YS.

PLoS One. 2016 Jan 14;11(1):e0146997. doi: 10.1371/journal.pone.0146997. eCollection 2016 Jan 14.

17.

Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery.

Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH, Poon LC.

Ultrasound Obstet Gynecol. 2015 Jan;45(1):101-5. doi: 10.1002/uog.14666. Epub 2014 Nov 28.

18.

Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.

Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM.

Clin Chem. 2006 Dec;52(12):2211-8. Epub 2006 Oct 26.

19.

Early pregnancy placental bed and fetal vascular volume measurements using 3-D virtual reality.

Reus AD, Klop-van der Aa J, Rifouna MS, Koning AH, Exalto N, van der Spek PJ, Steegers EA.

Ultrasound Med Biol. 2014 Aug;40(8):1796-803. doi: 10.1016/j.ultrasmedbio.2014.02.022. Epub 2014 May 3.

PMID:
24798392
20.

Placental volume measured by three-dimensional ultrasound in the prediction of fetal alpha(0)-thalassemia: a preliminary report.

Chen M, Leung KY, Lee CP, Tang MH, Ho PC.

Ultrasound Obstet Gynecol. 2006 Aug;28(2):166-72.

Supplemental Content

Support Center